-
Something wrong with this record ?
DNA damage and arterial hypertension. A systematic review and meta-analysis
R. Hazukova, M. Rezacova, M. Pleskot, Z. Zadak, E. Cermakova, M. Taborsky
Language English Country Czech Republic
Document type Meta-Analysis, Systematic Review, Journal Article, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
37916467
DOI
10.5507/bp.2023.044
Knihovny.cz E-resources
- MeSH
- 8-Hydroxy-2'-Deoxyguanosine MeSH
- Child MeSH
- Hypertension * MeSH
- Comet Assay MeSH
- Creatinine MeSH
- Humans MeSH
- DNA Damage * MeSH
- Aged MeSH
- Animals MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Aged MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Review MeSH
- Systematic Review MeSH
Oxidative DNA damage markers (8OHdG, comet assay, gammaH2AX) are becoming widely used in clinical cardiology research. To conduct this review of DNA damage in relation to hypertension in humans, we used databases (e.g. PubMed, Web of Science) to search for English-language publications up to June 30, 2022 and the terms: DNA damage, comet assay, gammaH2AX, 8OHdG, strand breaks, and arterial hypertension. Exclusion criteria were: children, absence of relevant controls, extra-arterial hypertensive issues, animal, cell lines. From a total of 79526, 15 human studies were selected. A total of 902 hypertensive patients (pts): (comet: N=418 pts; 8OHdG: N=484 pts) and 587 controls (comet: N=203; 8OHdG: N=384) were included. DNA damage was significantly higher in hypertensive pts than healthy controls (comet 26.6±11.0 vs 11.7±4.07 arbitrary units /A.U./; P<0.05 and="" 8ohdg="" 13="" 1="" 4="" 12="" vs="" 6="" 97="" 2="" 67="" ng="" mg="" creatinine="" i=""> P<0.05) confirmed with meta-analysis for both. Greater DNA damage was observed in more adverse cases (concentric cardiac hypertrophy 43.4±15.4 vs 15.6±5.5; sustained/untreated hypertension 31.4±12.1 vs 14.2±5/35.0±5.0 vs 25.0 ±5.0; non-dippers 39.2±15.5 vs 29.4±11.1 A.U.; elderly 14.9±4.5 vs 9.3±4.1 ng/mg creatinine; without carvedilol 9.1±4.2 vs 5.7±3.9; with coronary heart disease 0.5±0.1 vs 0.2±0.1 ng/mL) (P<0.05) confirmed with meta-analysis. DNA damage correlated strongly positively with serum glycosylated haemoglobin (r=0.670; P<0.05) and negatively with total antioxidant status (r=-0.670 to -0.933; P<0.05). This is the first systematic review with meta-analysis showing that oxidative DNA damage was increased in humans with arterial hypertension compared to controls.
Department of Cardiology and Internal Medicine Horice v Podkrkonosi Czech Republic
Department of Internal Medicine Pardubice Regional Hospital a s Pardubice Czech Republic
Departments of Research and Development University Hospital Hradec Kralove Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24005430
- 003
- CZ-PrNML
- 005
- 20250403105214.0
- 007
- ta
- 008
- 240404s2024 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2023.044 $2 doi
- 035 __
- $a (PubMed)37916467
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hazuková, Radka $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Internal Medicine, Pardubice Regional Hospital, a.s., Pardubice, Czech Republic $u Department of Cardiology and Internal Medicine (Profi-Kardio, s.r.o.), Horice v Podkrkonosi, Czech Republic $7 xx0066547
- 245 10
- $a DNA damage and arterial hypertension. A systematic review and meta-analysis / $c R. Hazukova, M. Rezacova, M. Pleskot, Z. Zadak, E. Cermakova, M. Taborsky
- 520 9_
- $a Oxidative DNA damage markers (8OHdG, comet assay, gammaH2AX) are becoming widely used in clinical cardiology research. To conduct this review of DNA damage in relation to hypertension in humans, we used databases (e.g. PubMed, Web of Science) to search for English-language publications up to June 30, 2022 and the terms: DNA damage, comet assay, gammaH2AX, 8OHdG, strand breaks, and arterial hypertension. Exclusion criteria were: children, absence of relevant controls, extra-arterial hypertensive issues, animal, cell lines. From a total of 79526, 15 human studies were selected. A total of 902 hypertensive patients (pts): (comet: N=418 pts; 8OHdG: N=484 pts) and 587 controls (comet: N=203; 8OHdG: N=384) were included. DNA damage was significantly higher in hypertensive pts than healthy controls (comet 26.6±11.0 vs 11.7±4.07 arbitrary units /A.U./; P<0.05 and="" 8ohdg="" 13="" 1="" 4="" 12="" vs="" 6="" 97="" 2="" 67="" ng="" mg="" creatinine="" i=""> P<0.05) confirmed with meta-analysis for both. Greater DNA damage was observed in more adverse cases (concentric cardiac hypertrophy 43.4±15.4 vs 15.6±5.5; sustained/untreated hypertension 31.4±12.1 vs 14.2±5/35.0±5.0 vs 25.0 ±5.0; non-dippers 39.2±15.5 vs 29.4±11.1 A.U.; elderly 14.9±4.5 vs 9.3±4.1 ng/mg creatinine; without carvedilol 9.1±4.2 vs 5.7±3.9; with coronary heart disease 0.5±0.1 vs 0.2±0.1 ng/mL) (P<0.05) confirmed with meta-analysis. DNA damage correlated strongly positively with serum glycosylated haemoglobin (r=0.670; P<0.05) and negatively with total antioxidant status (r=-0.670 to -0.933; P<0.05). This is the first systematic review with meta-analysis showing that oxidative DNA damage was increased in humans with arterial hypertension compared to controls.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a 8-hydroxy-2'-deoxyguanosin $7 D000080242
- 650 _2
- $a kreatinin $7 D003404
- 650 12
- $a poškození DNA $7 D004249
- 650 _2
- $a kometový test $7 D020552
- 650 12
- $a hypertenze $7 D006973
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Řezáčová, Martina, $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $d 1972- $7 nlk20020124956
- 700 1_
- $a Pleskot, Miloslav, $u Department of Cardiology and Internal Medicine (Profi-Kardio, s.r.o.), Horice v Podkrkonosi, Czech Republic $d 1953- $7 xx0057881
- 700 1_
- $a Zadák, Zdeněk, $u Departments of Research and Development, University Hospital, Hradec Kralove, Czech Republic $d 1937- $7 nlk19990074064
- 700 1_
- $a Čermáková, Eva, $u Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $d 1952- $7 mzk2007401286
- 700 1_
- $a Táborský, Miloš, $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1962- $7 jn20010310074
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 168, č. 1 (2024), s. 15-24
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37916467 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20240404 $b ABA008
- 991 __
- $a 20250403105209 $b ABA008
- 999 __
- $a ok $b bmc $g 2295213 $s 1215190
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 168 $c 1 $d 15-24 $e 20231030 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $n Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub $x MED00012606
- LZP __
- $b NLK116 $a Pubmed-20240404
